The Effect of Magnesium Deficiency on Neurological Disorders: A Narrative Review Article

被引:0
作者
Xue, Wenwen [1 ,2 ]
You, Jing [2 ]
Su, Yingchao [2 ]
Wang, Qinglu [1 ,3 ]
机构
[1] Qilu Med Univ, Key Lab Biomed Engn & Technol, Zibo, Peoples R China
[2] Univ North Texas, Coll Engn, Dept Biomed Engn, Denton, TX USA
[3] Shandong Normal Univ, Coll Life Sci, Jinan, Shandong, Peoples R China
关键词
Magnesium; Neurological disorders; Alzheimer's disease; Parkinson's disease; Stroke; Migraine; FOCAL CEREBRAL-ISCHEMIA; ALZHEIMERS-DISEASE; ACUTE STROKE; VASOSPASM; SULFATE; PATHOGENESIS; PREVENTION; POTASSIUM; THERAPY; CALCIUM;
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: Magnesium (Mg) is an essential element for the body. It is a cofactor for ATP, DNA, and RNA and more than 600 enzymes. As it is similar to Ca2+, this element can also act as a cell signaling molecule and play multiple important roles in the nervous, muscle, and immune systems. Recent studies have associated Mg-deficiency with many neurological disorders, such as cerebral vasospasm, Alzheimer's disease, stroke, and migraine. As it plays such a crucial role in human body, therefore, we summarized the role of Mg in neurological disorders to illustrate the symptoms caused by Mg-deficiency and the possible underlying mechanisms. Methods: We critically discuss the role of it that we review the recent literature of magnesium. We also review the available data which are concerning the role of magnesium in neurological disorders. Results: Magnesium is related to neurological disorders on the basis of the study of animals and humans experiments. Furthermore, these nervous systems related diseases include cerebral vasospasm, Alzheimer's disease, Parkinson's disease, stroke and migraine. Conclusion: Magnesium has effects on neurological disorders, such as its utility in cerebral vasospasm, Alzheimer's disease, Parkinson's disease, stroke and migraine. So here we make a brief review to conclude it.
引用
收藏
页码:379 / 387
页数:9
相关论文
共 61 条
[1]   Association between intakes of magnesium, potassium, and calcium and risk of stroke: 2 cohorts of US women and updated meta-analyses [J].
Adebamowo, Sally N. ;
Spiegelman, Donna ;
Willett, Walter C. ;
Rexrode, Kathryn M. .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 2015, 101 (06) :1269-1277
[2]   Recombinant Tissue-Type Plasminogen Activator Use for Ischemic Stroke in the United States A Doubling of Treatment Rates Over the Course of 5 Years [J].
Adeoye, Opeolu ;
Hornung, Richard ;
Khatri, Pooja ;
Kleindorfer, Dawn .
STROKE, 2011, 42 (07) :1952-1955
[3]  
Altura B., 2016, J Clin Case Studies, V1, P1, DOI DOI 10.16966/2471-4925.111
[4]   Comparison of the mineral content of tap water and bottled waters [J].
Azoulay A. ;
Garzon P. ;
Eisenberg M.J. .
Journal of General Internal Medicine, 2001, 16 (3) :168-175
[5]   Altered ionized magnesium levels in mild-to-moderate Alzheimer's disease [J].
Barbagallo, Mario ;
Belvedere, Mario ;
Di Bella, Giovanna ;
Dominguez, Ligia J. .
MAGNESIUM RESEARCH, 2011, 24 (03) :S115-S121
[6]   Magnesium: potential roles in neurovascular disease [J].
Chang, Jason J. ;
Mack, William J. ;
Saver, Jeffrey L. ;
Sanossian, Nerses .
FRONTIERS IN NEUROLOGY, 2014, 5
[7]   Acceleration of oligomerization, not fibrillization, is a shared property of both α-synuclein mutations linked to early-onset Parkinson's disease:: Implications for pathogenesis and therapy [J].
Conway, KA ;
Lee, SJ ;
Rochet, JC ;
Ding, TT ;
Williamson, RE ;
Lansbury, PT .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (02) :571-576
[8]   Nutraceuticals in Acute and Prophylactic Treatment of Migraine [J].
Daniel, Oved ;
Mauskop, Alexander .
CURRENT TREATMENT OPTIONS IN NEUROLOGY, 2016, 18 (04) :1-8
[9]   Efficacy of intravenous magnesium sulfate in the treatment of acute migraine attacks [J].
Demirkaya, S ;
Vural, O ;
Dora, B ;
Topçuoglu, MA .
HEADACHE, 2001, 41 (02) :171-177
[10]  
DORUP I, 1994, ACTA PHYSIOL SCAND, V150, P1